Literature DB >> 27805796

Implementation of a multicenter performance improvement program for early detection and treatment of severe sepsis in general medical-surgical wards.

Christa Schorr1, Andrew Odden2, Laura Evans3, Gabriel J Escobar4, Snehal Gandhi5, Sean Townsend6, Mitchell Levy7.   

Abstract

Sepsis is a leading cause of in-hospital death, and evidence suggests a higher mortality in patients presenting with sepsis on the ward compared to those presenting to the emergency department. Ward patients who develop severe sepsis may have poor outcomes for a variety of reasons, including delayed diagnosis, lack of readily available staffing, and delayed treatment. We report on a multihospital quality improvement program for early detection and treatment of sepsis on general medical-surgical wards. We describe a multipronged approach to improve severe sepsis outcomes using the Institute for Healthcare Improvement's Plan-Do-Study-Act model. Sixty sites engaged in a collaborative implementation process that aligned people, process, and technology. Based on our experience, we recommend a stepwise approach to implement such a program: (1) both administrative and clinical leadership commit to a common goal; (2) appoint clinical champions and give them authority to engage other clinicians to improve timeliness of interventions; (3) map workflows and processes to rely heavily on the nursing staff's ability to evaluate and report severe sepsis screening results; (4) if available, design and deploy technology with the assistance of clinical informaticians (eg, to enable electronic health records-based continuous screening); (5) to determine success, consider tracking screening compliance and process, and outcome measures such as length of stay and mortality. Journal of Hospital Medicine 2016;S11:32-S39.
© 2016 Society of Hospital Medicine. © 2016 Society of Hospital Medicine.

Entities:  

Mesh:

Year:  2016        PMID: 27805796     DOI: 10.1002/jhm.2656

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  9 in total

1.  Epidemiology of Hospital-Onset Versus Community-Onset Sepsis in U.S. Hospitals and Association With Mortality: A Retrospective Analysis Using Electronic Clinical Data.

Authors:  Chanu Rhee; Rui Wang; Zilu Zhang; David Fram; Sameer S Kadri; Michael Klompas
Journal:  Crit Care Med       Date:  2019-09       Impact factor: 7.598

2.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

3.  Compliance With the National SEP-1 Quality Measure and Association With Sepsis Outcomes: A Multicenter Retrospective Cohort Study.

Authors:  Chanu Rhee; Michael R Filbin; Anthony F Massaro; Amy L Bulger; Donna McEachern; Kathleen A Tobin; Barrett T Kitch; Bert Thurlo-Walsh; Aran Kadar; Alexandra Koffman; Anupam Pande; Yasir Hamad; David K Warren; Travis M Jones; Cara O'Brien; Deverick J Anderson; Rui Wang; Michael Klompas
Journal:  Crit Care Med       Date:  2018-10       Impact factor: 7.598

4.  Promoting early identification of sepsis in hospitalized patients with nurse-led protocols.

Authors:  Ruth Kleinpell
Journal:  Crit Care       Date:  2017-01-11       Impact factor: 9.097

5.  Opportunities for antibiotic optimisation and outcome improvement in patients with negative blood cultures: study protocol for a cluster-randomised crossover trial, the NO-BACT study.

Authors:  Silvia Jiménez-Jorge; Zaira R Palacios-Baena; Clara M Rosso-Fernández; José A Girón-Ortega; Jesús Rodriguez-Baño; Pilar Retamar
Journal:  BMJ Open       Date:  2019-12-18       Impact factor: 2.692

6.  Mortality of patients with hospital-onset sepsis in hospitals with all-day and non-all-day rapid response teams: a prospective nationwide multicenter cohort study.

Authors:  Dong-Gon Hyun; Su Yeon Lee; Jee Hwan Ahn; Jin Won Huh; Sang-Bum Hong; Younsuck Koh; Chae-Man Lim
Journal:  Crit Care       Date:  2022-09-16       Impact factor: 19.334

7.  Trends in mortality in septic patients according to the different organ failure during 15 years.

Authors:  Carolina Lorencio Cárdenas; Juan Carlos Yébenes; Emili Vela; Montserrat Clèries; Josep Mª Sirvent; Cristina Fuster-Bertolín; Clara Reina; Alejandro Rodríguez; Juan Carlos Ruiz-Rodríguez; Josep Trenado; Elisabeth Esteban Torné
Journal:  Crit Care       Date:  2022-10-03       Impact factor: 19.334

8.  Machine learning for early detection of sepsis: an internal and temporal validation study.

Authors:  Armando D Bedoya; Joseph Futoma; Meredith E Clement; Kristin Corey; Nathan Brajer; Anthony Lin; Morgan G Simons; Michael Gao; Marshall Nichols; Suresh Balu; Katherine Heller; Mark Sendak; Cara O'Brien
Journal:  JAMIA Open       Date:  2020-04-11

Review 9.  Current aspects in sepsis approach. Turning things around.

Authors:  F J Candel; M Borges Sá; S Belda; G Bou; J L Del Pozo; O Estrada; R Ferrer; J González Del Castillo; A Julián-Jiménez; I Martín-Loeches; E Maseda; M Matesanz; P Ramírez; J T Ramos; J Rello; B Suberviola; A Suárez de la Rica; P Vidal
Journal:  Rev Esp Quimioter       Date:  2018-06-25       Impact factor: 1.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.